BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 18725408)

  • 1. Characterization of the Ca2+ -regulated ezrin-S100P interaction and its role in tumor cell migration.
    Austermann J; Nazmi AR; Müller-Tidow C; Gerke V
    J Biol Chem; 2008 Oct; 283(43):29331-40. PubMed ID: 18725408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hierarchy of merlin and ezrin N- and C-terminal domain interactions in homo- and heterotypic associations and their relationship to binding of scaffolding proteins EBP50 and E3KARP.
    Nguyen R; Reczek D; Bretscher A
    J Biol Chem; 2001 Mar; 276(10):7621-9. PubMed ID: 11106646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ezrin interacts with S100A4 via both its N- and C-terminal domains.
    Biri-Kovács B; Kiss B; Vadászi H; Gógl G; Pálfy G; Török G; Homolya L; Bodor A; Nyitray L
    PLoS One; 2017; 12(5):e0177489. PubMed ID: 28493957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ca2+-dependent binding and activation of dormant ezrin by dimeric S100P.
    Koltzscher M; Neumann C; König S; Gerke V
    Mol Biol Cell; 2003 Jun; 14(6):2372-84. PubMed ID: 12808036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation and characterization of a novel, permanently active S100P mutant.
    Austermann J; Nazmi AR; Heil A; Fritz G; Kolinski M; Filipek S; Gerke V
    Biochim Biophys Acta; 2009 Jun; 1793(6):1078-85. PubMed ID: 19111582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100P and Ezrin promote trans-endothelial migration of triple negative breast cancer cells.
    Kikuchi K; McNamara KM; Miki Y; Iwabuchi E; Kanai A; Miyashita M; Ishida T; Sasano H
    Cell Oncol (Dordr); 2019 Feb; 42(1):67-80. PubMed ID: 30244410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ezrin interacts with the scaffold protein IQGAP1 and affects its cortical localization.
    Nammalwar RC; Heil A; Gerke V
    Biochim Biophys Acta; 2015 Sep; 1853(9):2086-94. PubMed ID: 25554515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ezrin self-association involves binding of an N-terminal domain to a normally masked C-terminal domain that includes the F-actin binding site.
    Gary R; Bretscher A
    Mol Biol Cell; 1995 Aug; 6(8):1061-75. PubMed ID: 7579708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ezrin mutants affecting dimerization and activation.
    Chambers DN; Bretscher A
    Biochemistry; 2005 Mar; 44(10):3926-32. PubMed ID: 15751968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble ezrin purified from placenta exists as stable monomers and elongated dimers with masked C-terminal ezrin-radixin-moesin association domains.
    Bretscher A; Gary R; Berryman M
    Biochemistry; 1995 Dec; 34(51):16830-7. PubMed ID: 8527459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open conformation of ezrin bound to phosphatidylinositol 4,5-bisphosphate and to F-actin revealed by neutron scattering.
    Jayasundar JJ; Ju JH; He L; Liu D; Meilleur F; Zhao J; Callaway DJ; Bu Z
    J Biol Chem; 2012 Oct; 287(44):37119-33. PubMed ID: 22927432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100P is a novel interaction partner and regulator of IQGAP1.
    Heil A; Nazmi AR; Koltzscher M; Poeter M; Austermann J; Assard N; Baudier J; Kaibuchi K; Gerke V
    J Biol Chem; 2011 Mar; 286(9):7227-38. PubMed ID: 21177863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The carboxyl-terminal region of EBP50 binds to a site in the amino-terminal domain of ezrin that is masked in the dormant molecule.
    Reczek D; Bretscher A
    J Biol Chem; 1998 Jul; 273(29):18452-8. PubMed ID: 9660814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional regulation and functional implication of S100P in cancer.
    Gibadulinova A; Tothova V; Pastorek J; Pastorekova S
    Amino Acids; 2011 Oct; 41(4):885-92. PubMed ID: 20155429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monomeric state of S100P protein: Experimental and molecular dynamics study.
    Permyakov SE; Denesyuk AI; Denessiouk KA; Permyakova ME; Kazakov AS; Ismailov RG; Rastrygina VA; Sokolov AS; Permyakov EA
    Cell Calcium; 2019 Jun; 80():152-159. PubMed ID: 31103949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of S100P, receptor for advanced glycation end products and ezrin in malignant melanoma.
    Zhu L; Ito T; Nakahara T; Nagae K; Fuyuno Y; Nakao M; Akahoshi M; Nakagawa R; Tu Y; Uchi H; Furue M
    J Dermatol; 2013 Dec; 40(12):973-9. PubMed ID: 24303922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The amino-terminal domains of the ezrin, radixin, and moesin (ERM) proteins bind advanced glycation end products, an interaction that may play a role in the development of diabetic complications.
    McRobert EA; Gallicchio M; Jerums G; Cooper ME; Bach LA
    J Biol Chem; 2003 Jul; 278(28):25783-9. PubMed ID: 12734202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct interaction of metastasis-inducing S100P protein with tubulin causes enhanced cell migration without changes in cell adhesion.
    Du M; Wang G; Barsukov IL; Gross SR; Smith R; Rudland PS
    Biochem J; 2020 Mar; 477(6):1159-1178. PubMed ID: 32065231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct interaction of 14-3-3ζ with ezrin promotes cell migration by regulating the formation of membrane ruffle.
    Chen M; Liu T; Xu L; Gao X; Liu X; Wang C; He Q; Zhang G; Liu L
    J Mol Biol; 2014 Sep; 426(18):3118-3133. PubMed ID: 25020230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promotion of the occurrence of endometrioid carcinoma by S100 calcium binding protein P.
    Zhang D; Chen X; Xia H; Wang L; Zhao H; Xu B; Zhang A; Zhang W
    BMC Cancer; 2020 Sep; 20(1):845. PubMed ID: 32883230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.